GHK-Cu price: the cheapest compound we track is also the least accurate

Key takeaways

GHK-Cu runs $20.00 to $89.00 across 22 vendors, among the cheapest in our market.
It also has the worst dose accuracy of any compound in our ledger: median miss of 22.7% from label.
That's nearly double the next worst. Only 2 of 11 vials landed within 5% of their label.
A low price tells you about supply and competition. It tells you nothing about the vial.

The number, and the number next to it

GHK-Cu is one of the cheapest things in our price market. As of the 25 July 2026 check, it runs $20.00 to $89.00 per package across 22 vendors.

Twenty-two sellers ties it with BPC-157 and MOTS-c for the most-stocked compound we track.

Cheap and everywhere. That combination reads as low-stakes, and here's the number that should sit beside it.

Across our lab records, the median GHK-Cu vial missed its labelled amount by 22.7%.

That's the worst dose accuracy of any compound in our testing ledger, and it isn't close.

The accuracy ranking

We computed the median absolute miss from label for every compound with at least three records carrying dose data.³

Compound	Records	Median miss from label	Within 5% of label
Ipamorelin	3	3.1%	2 of 3
Tesamorelin	7	3.8%	5 of 7
MOTS-c	5	5.0%	3 of 5
BPC-157	5	11.1%	0 of 5
Retatrutide	40	11.7%	7 of 40
Tirzepatide	33	13.1%	6 of 33
TB-500	4	13.2%	1 of 4
GHK-Cu	11	22.7%	2 of 11

GHK-Cu sits at the bottom by a wide margin. Its median miss is nearly double the next worst compound, and only 2 of its 11 vials landed within 5% of the label.

It's also the only compound in our ledger where vials came in under their labelled dose more often than over: 6 of 11 under, against a ledger-wide pattern where 98 of 112 records measured high.

Same nominal product, results running from 22.7% under to 24.4% over on vials all labelled 100mg. Purity, meanwhile, sat between 99.41% and 99.80% throughout.

Read only the purity column and every one of these looks excellent. That's the trap we describe in how to read a certificate of analysis: purity and quantity are different questions.

We aren't going to guess why GHK-Cu specifically behaves this way. Certificates can't distinguish filling practice from handling from the copper complex itself from measurement method.

What the price actually tells you

Not what people want it to.

A low price reflects supply and competition. Twenty-two vendors selling an unapproved compound with no approved product anchoring the market produces exactly this: a race downward with nothing underneath it.

Approved products carry a price floor set by manufacturing standards, oversight, and the cost of having gone through trials.¹ Nothing in this market carries any of that.

It doesn't reflect quality, and our accuracy table is the demonstration. The compound with the lowest floor price has the worst dose reliability, and the compound with among the best accuracy, tesamorelin, sits mid-range at $27.95 to $169.99.

Price and accuracy aren't related in either direction in this market. You cannot buy your way to a reliable vial, and a cheap vial isn't evidence of a bad one.

The one thing the range is good for is spotting outliers. Knowing GHK-Cu runs $20 to $89 means a $200 listing needs an explanation about package size.

Compare per milligram, not per package

The $20-to-$89 spread is 4.5x, which sounds dramatic until you remember these are package prices.

Different vial sizes, different quantities, different shipping origins all sit inside that range. A sticker price means nothing until the units match: cost per milligram, same quantity, same observation date.

And with GHK-Cu there's a second problem stacked on the first. If the labelled amount is off by a median of 22.7%, then cost per labelled milligram isn't cost per actual milligram.

You're doing arithmetic on a number the lab data says is unreliable. That's worth knowing before you build a spreadsheet on it.

Our price market normalizes and dates every observation so at least the first problem is solvable.

The other GHK-Cu market

Worth separating explicitly, because people arrive here from both directions.

The figures above describe research-vendor packages of injectable material, not authorized for human use.

Copper peptides also appear as ingredients in finished cosmetics, sold at retail, priced completely differently, and regulated as cosmetics rather than drugs. Those are separate products and separate markets, and a price from one says nothing about the other.

We go through why the evidence questions differ too in what GHK-Cu is.

What to do with this

Convert to cost per milligram before comparing anything.

Don't infer quality from price, in either direction. The data doesn't support it.

Ask for the dose column, not just purity, and treat the labelled amount as approximate. On this compound more than any other we track, it is.

Treat these figures as dated. Read 25 July 2026, and this market moves weekly.

For what else to check before buying from any vendor, see how to evaluate a peptide vendor. Marketing a cosmetic ingredient with treatment claims is separately the kind of unsupported health claim regulators police.²

Frequently asked questions

How much does GHK-Cu cost?

In our price market, GHK-Cu is listed from $20.00 to $89.00 per package across 22 vendors, as of the 25 July 2026 check. Those are package prices covering different vial sizes, so they are not directly comparable until you convert to cost per milligram at the same quantity.

Why is GHK-Cu so cheap compared to other peptides?

Because it is widely stocked and heavily competed on. Twenty-two vendors list it, tied for the most of any compound we track. Price in this market reflects supply and competition rather than quality or evidence, and GHK-Cu sits in our lowest evidence tier.

Does a cheap GHK-Cu vial mean lower quality?

Not directly, and the relationship does not run the other way either. What our lab records show is that GHK-Cu has the worst dose accuracy of anything we track regardless of price, with a median miss of 22.7% from the labelled amount and results running both under and over.

Is the GHK-Cu in skincare priced the same way?

No, and they are separate markets for separate products. Cosmetic products containing copper peptides are finished formulations sold at retail. The figures here describe research-vendor packages of injectable material, which is a different product with different rules and is not authorized for human use.